Suda, Goki
Furusyo, Norihiro
Toyoda, Hidenori
Kawakami, Yoshiiku
Ikeda, Hiroki
Suzuki, Michihiro
Arataki, Keiko
Mori, Nami
Tsuji, Keiji
Katamura, Yoshio
Takaguchi, Koichi
Ishikawa, Toru
Tsuji, Kunihiko
Shimada, Noritomo
Hiraoka, Atsushi
Yamsaki, Sho
Nakai, Masato
Sho, Takuya
Morikawa, Kenichi
Ogawa, Koji
Kudo, Mineo
Nagasaka, Atsushi
Furuya, Ken
Yamamoto, Yoshiya
Kato, Kanji
Ueno, Yoshiyuki
Iio, Etsuko
Tanaka, Yasuhito
Kurosaki, Masayuki
Kumada, Takashi
Chayama, Kazuaki
Sakamoto, Naoya
Clinical trials referenced in this document:
Documents that mention this clinical trial
Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in Japan
https://doi.org/10.1007/s00535-017-1353-y
Article History
Received: 27 February 2017
Accepted: 22 May 2017
First Online: 30 May 2017
Compliance with ethical standards
:
: N. Sakamoto received lecture fees from Bristol Myers Squibb and Pharmaceutical K.K., grants and endowments from MSD K.K. and Chugai Pharmaceutical Co., Ltd., and a research grant from Gilead Sciences, Inc. G. Suda received research grants from Bristol Myers Squibb. K. Chayama has received research grants and consulting fees from Bristol-Myers Squibb, Dainippon Sumitomo Pharma, Mitsubishi Tanabe Pharma, Daiichi Sankyo, Toray Industries, Otsuka Pharmaceutical Company, and GlaxoSmithKline K.K. Y. Ueno has received research grants from Bristol-Myers Squibb, MSD K.K., Gilead Sciences, Inc., and AbbVie G.K. K. Furuya has received lecture fees from Bristol-Myers Squibb and MSD K.K. H. Toyoda and T. Kumada received research grants from Bristol Myers Squibb. K. Takaguchi has received lecture fees from Bristol-Myers Squibb. Y. Tanaka have received lecture fees from Bristol-Myers Squibb, MSD K.K., Chugai Pharmaceutical Co., Ltd., AbbVie Inc., Janssen Pharmaceutical K.K., Gilead Sciences, and a research grant from Bristol-Myers Squibb, Chugai Pharmaceutical Co., Ltd,, and AbbVie Inc. The other authors have nothing to disclose.
: This study was supported in part by grants from the Japan Agency for Medical Research and Development.